NCT00328536View on ClinicalTrials.gov

Omacor for the Treatment of Vascular Dysfunction in Patients With Type 2 Diabetes Mellitus

PHASE4CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

November 30, 2008

Study Completion Date

November 30, 2008

Conditions
AtherosclerosisType 2 Diabetes Mellitus
Interventions
DRUG

Omacor

Trial Locations (1)

32545

Heart- and Diabetes Centre NRW, Diabetes Clinic, Bad Oeynhausen

All Listed Sponsors
collaborator

Heart and Diabetes Center North-Rhine Westfalia

OTHER

collaborator

Solvay Pharmaceuticals

INDUSTRY

lead

Ruhr University of Bochum

OTHER

NCT00328536 - Omacor for the Treatment of Vascular Dysfunction in Patients With Type 2 Diabetes Mellitus | Biotech Hunter | Biotech Hunter